Clinical trials of neural transplantation in Huntington's disease

Progress in Brain Research

Volumn 200, Issue , 2012, Pages 345-371

  Rosser, Anne E ^a,d   Bachoud Lévi, Anne Catherine ^b,c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c ECOLE NORMALE SUPÉRIEURE   (France)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Clinical trials; Human tissue; Huntington's disease; Primary fetal tissue; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISOLONE;

ARTICLE; AUTOPSY; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); DONOR; HISTOPATHOLOGY; HUMAN; HUNTINGTON CHOREA; IMMUNOSUPPRESSIVE TREATMENT; MEDIAN EMINENCE; NERVE CELL PLASTICITY; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84870259528     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59575-1.00016-8     Document Type: Chapter

References (85)

1. Bachoud-Lévi A.C. Neural grafts in Huntington's disease: viability after 10 years. Lancet Neurol. 2009, 8:979-981.
2. Bachoud-Lévi A.C., Rémy P., Nguyen J.P., Brugières P., Lefaucheur J.P., Bourdet C., Baudic S., Gaura V., Maison P., Haddad B., Boissé M.F., Grandmougin T., Jény R., Bartolomeo P., Dalla Barba G., Degos J.D., Lisovoski F., Ergis A.M., Pailhous E., Césaro P., Hantraye P., Peschanski M. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000, 356:1975-1979.
3. Bachoud-Lévi A.C., Maison P., Bartolomeo P., Boissé M.F., Dalla Barba G., Ergis A.M., Baudic S., Degos J.D., Césaro P., Peschanski M. Retest effects and cognitive decline in longitudinal follow-up of patients with early HD. Neurology 2001, 56:1052-1058.
4. Bachoud-Lévi A.C., Hantraye P., Peschanski M. Fetal neural grafts for Huntington's disease: a prospective view. Mov. Disord. 2002, 17:439-444.
5. Bachoud-Lévi A.C., Gaura V., Brugières P., Lefaucheur J.P., Boissé M.F., Maison P., Baudic S., Ribeiro M.J., Bourdet C., Rémy P., Césaro P., Hantraye P., Peschanski M. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol. 2006, 5:303-309.
6. Barker R.A., Kendall A.L., Widner H. Neural tissue xenotransplantation: what is needed prior to clinical trials in Parkinson's disease? Neural Tissue Xenografting Project. Cell Transplant. 2000, 9:235-246.
7. Barker, R.A., Mason, S., Harrower, T.P., Swain, R.A., Ho, A.K., Sahakian, B.J., Mathur, R., Elneil, S., Thornton, S., Hurrelbrink, C., Armstrong, R., Tyers, P., Smith, E., Carpenter, A., Piccini, P., Tai, Y., Brooks, D.J., Pavese, N., Watts, C., Pickard, J.D., Rosser, A.E., Dunnett, S.B., the NEST-UK collaboration, submitted. The long term safety and efficacy of bilateral transplantation of human foetal striatal tissue in patients with mild to moderate Huntington's disease. J. Neurol. Neurosurg. Psychiatry. (in revision).
8. Besret L., Kendall A.L., Dunnett S.B. Aspects of PET imaging relevant to the assessment of striatal transplantation in Huntington's disease. J. Anat. 2000, 196:597-607.
9. Boer G.J., Widner H. Clinical neurotransplantation: core assessment protocol rather than sham surgery as control. Brain Res. Bull. 2002, 58:547-553.
10. Brasted P.J., Watts C., Torres E.M., Robbins T.W., Dunnett S.B. Behavioral recovery after transplantation into a rat model of Huntington's disease: dependence on anatomical connectivity and extensive postoperative training. Behav. Neurosci. 2000, 114:431-436.
11. Brundin P., Strecker R.E., Widner H., Clarke D.J., Nilsson O.G., Astedt B., Lindvall O., Björklund A. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp. Brain Res. 1988, 70:192-208.
12. Campbell K., Wictorin K., Björklund A. Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents. Proc. Natl. Acad. Sci. USA 1992, 89:10489-10493.
13. Campbell K., Kalen P., Wictorin K., Lundberg C., Mandel R.J., Björklund A. Characterization of GABA release from intrastriatal striatal transplants: dependence on host-derived afferents. Neuroscience 1993, 53:403-415.
14. Capetian P., Knoth R., Maciaczyk J., Pantazis G., Ditter M., Bokla L., Landwehrmeyer G.B., Volk B., Nikkhah G. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation. Neuroscience 2009, 160:661-675.
15. Carson M.J., Doose J.M., Melchior B., Schmid C.D., Ploix C.C. CNS immune privilege: hiding in plain sight. Immunol. Rev. 2006, 213:48-65.
16. Cicchetti F., Saporta S., Hauser R.A., Parent M., Saint-Pierre M., Sanberg P.R., Li X.J., Parker J.R., Chu Y., Mufson E.J., Kordower J.H., Freeman T.B. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc. Natl. Acad. Sci. USA 2009, 106:12483-12488.
17. Clarke D.J., Dunnett S.B. Synaptic relationships between cortical and dopaminergic inputs and intrinsic GABAergic systems within intrastriatal striatal grafts. J. Chem. Neuroanat. 1993, 6:147-158.
18. Clarke D.J., Dunnett S.B., Isacson O., Sirinathsinghji D.J., Björklund A. Striatal grafts in rats with unilateral neostriatal lesions-I. Ultrastructural evidence of afferent synaptic inputs from the host nigrostriatal pathway. Neuroscience 1988, 24:791-801.
19. Clarke D.J., Wictorin K., Dunnett S.B., Bolam J.P. Internal composition of striatal grafts: light and electron microscopy. The Basal Ganglia IV. New Ideas on Structure and Function 1994, 189-196. Plenum Press, New York. G. Percheron, J.S. McKenzie, J. Féger (Eds.).
20. Deacon T.W., Pakzaban P., Isacson O. The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: neural transplantation and developmental evidence. Brain Res. 1994, 668:211-219.
21. Döbrössy M.D., Dunnett S.B. The influence of environment and experience on neural grafts. Nat. Rev. Neurosci. 2001, 2:871-879.
22. Dunnett S.B., Rosser A.E. Cell-based treatments for Huntington's disease. Int. Rev. Neurobiol. 2011, 98:483-508.
23. Dunnett S.B., White A. Striatal grafts alleviate bilateral striatal lesion deficits in operant delayed alternation in the rat. Exp. Neurol. 2006, 199:479-489.
24. Dunnett S.B., Nathwani F., Björklund A. The integration and function of striatal grafts. Prog. Brain Res. 2000, 127:345-380.
25. Ferrante R.J. Mouse models of Huntington's disease and methodological considerations for therapeutic trials. Biochim. Biophys. Acta 2009, 1792:506-520.
26. Freeman T.B., Cicchetti F., Hauser R.A., Deacon T.W., Li X.J., Hersch S.M., Nauert G.M., Sanberg P.R., Kordower J.H., Saporta S., Isacson O. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc. Natl. Acad. Sci. USA 2000, 97:13877-13882.
27. Freeman T.B., Cicchetti F., Bachoud-Lévi A.C., Dunnett S.B. Technical factors that influence neural transplant safety in Huntington's disease. Exp. Neurol. 2011, 227:1-9.
28. Fricker R.A., Torres E.M., Hume S.P., Myers R., Opacka-Juffry J., Ashworth S., Brooks D.J., Dunnett S.B. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour. Neuroscience 1997, 79:711-721.
29. Furtado S., Sossi V., Hauser R.A., Samii A., Schulzer M., Murphy C.B., Freeman T.B., Stoessl A.J. Positron emission tomography after fetal transplantation in Huntington's disease. Ann. Neurol. 2005, 58:331-337.
30. Gallina P., Paganini M., Di Rita A., Lombardini L., Moretti M., Vannelli G.B., Di Lorenzo N. Human fetal striatal transplantation in Huntington's disease: a refinement of the stereotactic procedure. Stereotact. Funct. Neurosurg. 2008, 86:308-313.
31. Gallina P., Paganini M., Lombardini L., Saccardi R., Marini M., De Cristofaro M.T., Pinzani P., Salvianti F., Crescioli C., Di Rita A., Bucciantini S., Mechi C., Sarchielli E., Moretti M., Piacentini S., Gritti G., Bosi A., Sorbi S., Orlandini G., Vannelli G.B., Di Lorenzo N. Development of human striatal anlagen after transplantation in a patient with Huntington's disease. Exp. Neurol. 2008, 213:241-244.
32. Gallina P., Paganini M., Lombardini L., Mascalchi M., Porfirio B., Gadda D., Marini M., Pinzani P., Salvianti F., Crescioli C., Bucciantini S., Mechi C., Sarchielli E., Romoli A.M., Bertini E., Urbani S., Bartolozzi B., De Cristofaro M.T., Piacentini S., Saccardi R., Pupi A., Vannelli G.B., Di Lorenzo N. Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation. Exp. Neurol. 2010, 222:30-41.
33. Gaura V., Bachoud-Lévi A.C., Ribeiro M.J., Nguyen J.P., Frouin V., Baudic S., Brugières P., Mangin J.F., Boissé M.F., Palfi S., Césaro P., Samson Y., Hantraye P., Peschanski M., Rémy P. Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain 2004, 127:65-72.
34. Graybiel A.M., Liu F.C., Dunnett S.B. Intrastriatal grafts derived from fetal striatal primordia. I. Phenotypy and modular organization. J. Neurosci. 1989, 9:3250-3271.
35. Hantraye P., Riche D., Mazière M., Isacson O. A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon. Exp. Neurol. 1990, 108:91-104.
36. Hauser R.A., Sandberg P.R., Freeman T.B., Stoessl A.J. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 2002, 58:1704. author reply 1704.
37. Helm G.A., Palmer P.E., Bennett J.P. Choline acetyltransferase- and substance P-like immunoreactive elements in fetal striatal grafts in the rat: a correlated light and electron microscopic study. Neuroscience 1992, 47:621-639.
38. Huntington's Disease Study Group (HSG) The Unified Huntington's Disease Rating Scale: Reliability and Consistency. Mov. Dis. 1996, 11:136-142.
39. Hurelbrink C.B., Armstrong R.J., Barker R.A., Dunnett S.B., Rosser A.E. Hibernated human fetal striatal tissue: successful transplantation in a rat model of Huntington's disease. Cell Transplant. 2000, 9:743-749.
40. Hurelbrink C.B., Tyers P., Armstrong R.J., Dunnett S.B., Barker R.A., Rosser A.E. Long-term hibernation of human fetal striatal tissue does not adversely affect its differentiation in vitro or graft survival: implications for clinical trials in Huntington's disease. Cell Transplant. 2003, 12:687-695.
41. Isacson O., Brundin P., Kelly P.A., Gage F.H., Björklund A. Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum. Nature 1984, 311:458-460.
42. Isacson O., Brundin P., Gage F.H., Björklund A. Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting. Neuroscience 1985, 16:799-817.
43. Keene C.D., Sonnen J.A., Swanson P.D., Kopyov O., Leverenz J.B., Bird T.D., Montine T.J. Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology 2007, 68:2093-2098.
44. Kelly C.M., Precious S.V., Penketh R., Amso N., Dunnett S.B., Rosser A.E. Striatal graft projections are influenced by donor cell type and not the immunogenic background. Brain 2007, 130:1317-1329.
45. Kelly C.M., Precious S.V., Scherf C., Penketh R., Amso N.N., Battersby A., Allen N.D., Dunnett S.B., Rosser A.E. Neonatal desensitization allows long-term survival of neural xenotransplants without immunosuppression. Nat. Methods 2009, 6:271-273.
46. Kelly C.M., Precious S.V., Torres E.M., Harrison A.W., Williams D., Scherf C., Weyrauch U.M., Lane E.L., Allen N.D., Penketh R., Amso N.N., Kemp P.J., Dunnett S.B., Rosser A.E. Medical terminations of pregnancy: a viable source of tissue for cell replacement therapy for neurodegenerative disorders. Cell Transplant. 2011, 20:503-513.
47. Kendall A.L., Rayment F.D., Torres E.M., Baker H.F., Ridley R.M., Dunnett S.B. Functional integration of striatal allografts in a primate model of Huntington's disease. Nat. Med. 1998, 4:727-729.
48. Kendall A.L., Hantraye P., Palfi S. Striatal tissue transplantation in non-human primates. Prog. Brain Res. 2000, 127:381-404.
49. Kopyov O.V., Jacques S., Lieberman A., Duma C.M., Eagle K.S. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp. Neurol. 1998, 149:97-108.
50. Kordower J.H., Chu Y., Hauser R.A., Freeman T.B., Olanow C.W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 2008, 14:504-506.
51. Krystkowiak P., Gaura V., Labalette M., Rialland A., Rémy P., Peschanski M., Bachoud-Lévi A.C. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PLoS One 2007, 2:e166.
52. Li J.Y., Englund E., Holton J.L., Soulet D., Hagell P., Lees A.J., Lashley T., Quinn N.P., Rehncrona S., Björklund A., Widner H., Revesz T., Lindvall O., Brundin P. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 2008, 14:501-503.
53. Liu F.C., Graybiel A.M., Dunnett S.B., Baughman R.W. Intrastriatal grafts derived from fetal striatal primordia. II. Reconstitution of cholinergic and dopaminergic systems. J. Comp. Neurol. 1990, 295:1-14.
54. Liu F.C., Dunnett S.B., Graybiel A.M. Intrastriatal grafts derived from fetal striatal primordia. IV. Host and donor neurons are not intermixed. Neuroscience 1993, 55:363-372.
55. Madrazo I., Cuevas C., Castrejon H., Guizar-Sahagun G., Franco-Bourland R.E., Ostrosky-Solis F., Aguilera M., Magallon E. The first homotopic fetal homograft of the striatum in the treatment of Huntington's disease. Gac. Med. Mex. 1993, 129:109-117.
56. Madrazo I., Franco-Bourland R.E., Castrejon H., Cuevas C., Ostrosky-Solis F. Fetal striatal homotransplantation for Huntington's disease: first two case reports. Neurol. Res. 1995, 17:312-315.
57. Magavi S.S., Lois C. Transplanted neurons form both normal and ectopic projections in the adult brain. Dev. Neurobiol. 2008, 68:1527-1537.
58. Mayer E., Brown V.J., Dunnett S.B., Robbins T.W. Striatal graft-associated recovery of a lesion-induced performance deficit in the rat requires learning to use the transplant. Eur. J. Neurosci. 1992, 4:119-126.
59. Mendez I., Vinuela A., Astradsson A., Mukhida K., Hallett P., Robertson H., Tierney T., Holness R., Dagher A., Trojanowski J.Q., Isacson O. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat. Med. 2008, 14:507-509.
60. Mestre T.A., Ferreira J.J. An evidence-based approach in the treatment of Huntington's disease. Parkinsonism Relat. Disord. 2012, 18:316-320.
61. Novak M.J., Tabrizi S.J. Huntington's disease: clinical presentation and treatment. Int. Rev. Neurobiol. 2011, 98:297-323.
62. Olsson M., Campbell K., Wictorin K., Björklund A. Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence. Neuroscience 1995, 69:1169-1182.
63. Olsson M., Björklund A., Campbell K. Early specification of striatal projection neurons and interneuronal subtypes in the lateral and medial ganglionic eminence. Neuroscience 1998, 84:867-876.
64. Pakzaban P., Isacson O. Neural xenotransplantation: reconstruction of neuronal circuitry across species barriers. Neuroscience 1994, 62:989-1001.
65. Pakzaban P., Deacon T.W., Burns L.H., Isacson O. Increased proportion of acetylcholinesterase-rich zones and improved morphological integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence. Exp. Brain Res. 1993, 97:13-22.
66. Paynter S.J., Andrews K.J., Vinh N.N., Kelly C.M., Rosser A.E., Amso N.N., Dunnett S.B. Membrane permeability coefficients of murine primary neural brain cells in the presence of cryoprotectant. Cryobiology 2009, 58:308-314.
67. Peschanski M., Bachoud-Lévi A.C., Hantraye P. Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease. Brain 2004, 127:1219-1228.
68. Philpott L.M., Kopyov O.V., Lee A.J., Jacques S., Duma C.M., Caine S., Yang M., Eagle K.S. Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: three case presentations. Cell Transplant. 1997, 6:203-212.
69. Pritzel M., Isacson O., Brundin P., Wiklund L., Björklund A. Afferent and efferent connections of striatal grafts implanted into the ibotenic acid lesioned neostriatum in adult rats. Exp. Brain Res. 1986, 65:112-126.
70. Quinn N., Brown R., Craufurd D., Goldman S., Hodges J., Kieburtz K., Lindvall O., MacMillan J., Roos R. Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD). Mov. Disord. 1996, 11:143-150.
71. Reuter I., Tai Y.F., Pavese N., Chaudhuri K.R., Mason S., Polkey C.E., Clough C., Brooks D.J., Barker R.A., Piccini P. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. J. Neurol. Neurosurg. Psychiatry 2008, 79:948-951.
72. Rosser A.E., Barker R.A., Harrower T., Watts C., Farrington M., Ho A.K., Burnstein R.M., Menon D.K., Gillard J.H., Pickard J., Dunnett S.B. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. J. Neurol. Neurosurg. Psychiatry 2002, 73:678-685.
73. Rosser A.E., Barker R.A., Armstrong R.J., Elneil S., Jain M., Hurelbrink C.B., Prentice A., Carne C., Thornton S., Hutchinson H., Dunnett S.B. Staging and preparation of human fetal striatal tissue for neural transplantation in Huntington's disease. Cell Transplant. 2003, 12:679-686.
74. Sanberg P.R., Coyle J.T. Scientific approaches to Huntington's disease. CRC Crit. Rev. Clin. Neurobiol. 1984, 1:1-44.
75. Sramka M., Rattaj M., Molina H., Vojtassak J., Belan V., Ruzicky E. Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington's chorea. Stereotact. Funct. Neurosurg. 1992, 58:79-83.
76. Sykova E., Jendelova P. In vivo tracking of stem cells in brain and spinal cord injury. Prog. Brain Res. 2007, 161:367-383.
77. Torres E.M., Fricker R.A., Hume S.P., Myers R., Opacka-Juffry J., Ashworth S., Brooks D.J., Dunnett S.B. Assessment of striatal graft viability in the rat in vivo using a small diameter PET scanner. Neuroreport 1995, 6:2017-2021.
78. Watts C., Brasted P.J., Dunnett S.B. Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease. Exp. Neurol. 2000, 163:85-97.
79. Wictorin K. Anatomy and connectivity of intrastriatal striatal transplants. Prog. Neurobiol. 1992, 38:611-639.
80. Wictorin K., Isacson O., Fischer W., Nothias F., Peschanski M., Björklund A. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum-I. Subcortical afferents. Neuroscience 1988, 27:547-562.
81. Wictorin K., Clarke D.J., Bolam J.P., Björklund A. Host corticostriatal fibres establish synaptic connections with grafted striatal neurons in the ibotenic acid lesioned striatum. Eur. J. Neurosci. 1989, 1:189-195.
82. Wictorin K., Ouimet C.C., Björklund A. Intrinsic organization and connectivity of intrastriatal striatal transplants in rats as revealed by DARPP-32 immunohistochemistry: specificity of connections with the lesioned host brain. Eur. J. Neurosci. 1989, 1:690-701.
83. Wictorin K., Simerly R.B., Isacson O., Swanson L.W., Björklund A. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum-III. Efferent projecting graft neurons and their relation to host afferents within the grafts. Neuroscience 1989, 30:313-330.
84. Wictorin K., Brundin P., Gustavii B., Lindvall O., Björklund A. Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts. Nature 1990, 347:556-558.
85. Wictorin K., Clarke D.J., Bolam J.P., Björklund A. Fetal striatal neurons grafted into the ibotenate lesioned adult striatum: efferent projections and synaptic contacts in the host globus pallidus. Neuroscience 1990, 37:301-315.